Navigation Links
POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009
Date:5/26/2009

Rapid advancements in producing cellulosic ethanol and the fuel's promise for the future will be highlighted by POET next week at Ethanol Summit 2009 in Sao Paulo, Brazil.

Sioux Falls, S.D. (Vocus) May 26, 2009-- Rapid advancements in producing cellulosic ethanol and the fuel's promise for the future will be highlighted by POET next week at Ethanol Summit 2009 in Sao Paulo, Brazil.

POET Director of Corporate Affairs Doug Berven will be one of four panelists in a plenary session titled "Second Generation Ethanol: Realities and Possibilities" from 2-4 p.m. Monday, June 1 at the Sheraton World Trade Center in Sao Paulo. Joining Berven will be Novozymes CEO Steen Riisgaard, CanaVialis-Monsanto President Ricardo Madureira and BP Biofuels General Manager for Technology Ian Dobson.

POET will produce cellulosic ethanol from corn cobs in 2011 through Project LIBERTY, a $200 million plant to be built in Emmetsburg, Iowa. POET's pilot plant in Scotland, S.D. is already using that process to produce ethanol at a rate of 20,000 gallons per year.

Ethanol Summit 2009 is a platform for in-depth discussions on the present and future of biofuels in Brazil and the world, with special focus on ethanol. The event features specialists, researchers, leading business executives and government officials from around the world. Former President Bill Clinton will be a keynote speaker at the event. The summit takes place June 1-3.

To download a photo of Doug Berven, go to http://www.poet.com/news/showRelease.asp?id=168. To see a documentary about POET's pilot cellulosic ethanol plant visit www.poet.com/cellulosedocumentary.htm. Media outlets are welcome to link to the documentary in online coverage. Photos are also available for publication at http://www.poet.com/news/releases.asp.

About POET
POET, the largest ethanol producer in the world, is a leader in biorefining through its efficient, vertically integrated approach to production. The 20-year-old company produces more than 1.54 billion gallons of ethanol annually from 26 production facilities nationwide. POET recently started up a pilot-scale cellulosic ethanol plant, which uses corn cobs as feedstock, and will commercialize the process in 2011. For more information, visit www.poet.com.

CONTACT:
Matt Merritt, Media Relations Specialist
Phone: (605) 965-2225 / (605) 370-9959

###

Read the full story at http://www.prweb.com/releases/POET/Cellulosic_Ethanol/prweb2462974.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Dynamic Outlines Initial Target Markets for Pharmaceutical Cannabinoid Products
2. Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters
3. Intervet/Schering-Plough Animal Health Outlines Strength of the Combination
4. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
5. Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
6. Researchers outline structure of largest nonvirus particle ever crystallized
7. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
8. Solazyme Testing BlueFire Ethanol Cellulosic Sugars in Its Microalgae Renewable Oil Production Process
9. Research Reinforces Economic, Environmental Benefits of Corn Cobs as Source for Cellulosic Ethanol
10. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
11. Verenium Announces First Commercial Cellulosic Ethanol Project
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009 
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):